NCT Number: NCT04606446
Phase: Phase 1
Trial Summary: This is an open-label, multi center study to evaluate safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of PF-07248144 and early signs of clinical efficacy of – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Pfizer
Acronym: KAT6
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives